Trinity Biotech Plc (TRIB)
0.598
0.00 (0.00%)
USD |
NASDAQ |
Apr 02, 11:11
Trinity Biotech Research and Development Expense (TTM) : 4.019M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amarin Corp. Plc | 16.82M |
| DBV Technologies SA | 107.07M |
| Cellectis SA | 75.00M |
| Akari Therapeutics Plc | 2.820M |
| Biodexa Pharmaceuticals Plc | 5.234M |